ArticleEuropean journal of heart failure2019

Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure.

William T Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.